Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Bioorg Chem ; 149: 107512, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38833990

ABSTRACT

Ras-related C3 botulinum toxin substrate 1 (Rac1) has emerged as a key regulator in the treatment of cancer metastasis because of its involvement in the formation of cell plate pseudopods and effects on cell migration. In this study, we found that incarvine C, a natural product isolated from Incarvillea sinensis, and its seven analogues exhibited antitumour activity by inhibiting cell cytoskeleton formation, with moderate cytotoxicity. Accordingly, these compounds inhibited the cytoskeleton-mediated migration and invasion of MDA-MB-231 cells, with inhibition rates ranging from 37.30 % to 69.72 % and 51.27 % to 70.90 % in vitro, respectively. Moreover, they induced G2/M phase cell cycle arrest in MDA-MB-231 cells. A pull-down assay revealed that the interaction between Rac1 and its downstream effector protein PAK1 was inhibited by these compounds and that the compound Ano-6 exhibited substantial activity, with an inhibition rate of more than 90 %. Molecular docking showed that incarvine C and its analogues could bind to the nucleotide-binding pocket of Rac1, maintaining high levels of inactivated Rac1. As Ano-6 exhibited significant activity in vitro, its anti-cancer activity was tested in vivo. Four weeks of oral treatment with Ano-6 was well-tolerated in mice, and it induced a potential anti-tumour response in xenografts of MDA-MB-231 cells. Further studies demonstrated that Ano-6 was enriched in tumour tissues after 2 h of administration and induced an increase in the number of dead tumour cells. In summary, these findings not only reveal the mechanism of incarvine C but also provide a new molecular template for Rac1 inhibitors and identify a promising candidate for breast cancer treatment.


Subject(s)
Cytoskeleton , Drug Screening Assays, Antitumor , Molecular Docking Simulation , rac1 GTP-Binding Protein , rac1 GTP-Binding Protein/metabolism , rac1 GTP-Binding Protein/antagonists & inhibitors , Humans , Animals , Cytoskeleton/drug effects , Cytoskeleton/metabolism , Molecular Structure , Structure-Activity Relationship , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/chemical synthesis , Mice , Dose-Response Relationship, Drug , Cell Proliferation/drug effects , Cell Movement/drug effects , Cell Line, Tumor , Female , Mice, Nude , Mice, Inbred BALB C
2.
Chem Biodivers ; 20(4): e202201203, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36896496

ABSTRACT

A novel monoterpene alkaloid, named incarvine G, was isolated from the Incarvillea sinensis Lam. Its chemical structure was elucidated using comprehensive spectroscopic methods. Incarvine G is an ester compound comprised of a monoterpene alkaloid and glucose. This compound showed evident inhibition on cell migration, invasion, and cytoskeleton formation of human MDA-MB-231 with low cytotoxicity.


Subject(s)
Antineoplastic Agents , Bignoniaceae , Monoterpenes , Humans , Alkaloids/pharmacology , Alkaloids/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Bignoniaceae/chemistry , Molecular Structure , Monoterpenes/pharmacology , Monoterpenes/chemistry , Cell Migration Inhibition/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL